pharma-company /Medicinal products /Active ingredients

Rx · PZN 11538079, 11538085, 11538091

HYDROMORPHONE HCl Hormosan 4 mg prolonged-release tablets

German trade nameHYDROMORPHON HCl Hormosan 4 mg Retardtabletten

Active ingredientHydromorphoneSubstance (DE)HydromorphonPharmaceutical formProlonged-release tablets

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €34

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

HYDROMORPHONE HCl Hormosan 4 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

HYDROMORPHONE HCl Hormosan 4 mg prolonged-release tablets contains the active ingredient Hydromorphone (German Hydromorphon) and comes as Prolonged-release tablets. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 9.6 out of 10 over the past 30 days.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
115380799.49.6~ €11
115380859.49.6~ €30
115380919.49.6~ €60

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 3 recorded PZNs.